UFC welterweight George Sullivan has received a one-year suspension from the sport by the U.S Anti-Doping Agency (USADA).
Sullivan received a one-year suspension following his second positive drug test.
On Tuesday, USADA sent out a statement regarding Sullivan’s suspension.
“After a thorough review of the case, including the examination of medical records provided by the athlete, USADA confirmed that Sullivan’s positive test was caused by Clomiphene Citrate, which he was using in a therapeutic dose under the care of a physician to treat a medical condition. The prescribed use of the medication by Sullivan is considered an ‘off-label’ treatment, as Clomiphene Citrate is not approved by the U.S. Food & Drug Administration for use by males.
“In this instance, USADA determined that Sullivan’s degree of fault was reduced because his use of Clomiphene Citrate was under the care of his physician for a documented medical condition. Accordingly, Sullivan received a reduction to one year from the standard two-year period of ineligibility that could have been imposed for a second offense involving a Specified Substance.”
Sullivan has not competed in the UFC for over a year. He is coming off a knockout loss to Alexander Yakolev back in January 2016. He has an overall UFC record of 3-2.
Sullivan was scheduled to fight earlier this year at UFC 208 in February. However, he was forced off the card after testing positive for a banned substance.
